Abstract
Background:
PAXgene® Blood RNA tubes are routinely used in clinical research and molecular biology applications to preserve the stability of RNA in whole blood. However, in practice, blood clots are occasionally observed after blood collection and are often ignored. Currently, there are few studies on whether blood clots affect the quality of RNA extracted from these tubes.
Materials and Methods:
Fifteen pairs of non-clot and clot PAXgene Blood RNA tube samples (
Results:
The median yields of RNA from the non-clot and clot groups were 3.84 (2.80–6.38) μg and 4.87 (2.77–8.30) μg, respectively. The median A260/280 ratios were 2.08 (2.06–2.09) and 2.09 (2.07–2.11), whereas the median A260/230 ratios were 1.77 (1.31–1.91) and 1.67 (1.21–1.94) in the two groups. In addition, the median RINs were 8.20 (8.00–8.40) and 7.20 (6.60–7.70), respectively. There were no significant differences in RNA yields, A260/280, or A260/230 between the two groups. However, the RIN value of the clot group was significantly lower compared with the non-clot group (
Conclusions:
The formation of large blood clots in PAXgene Blood RNA tubes will reduce the integrity of extracted RNA.
Get full access to this article
View all access options for this article.
